Lightcast Discovery
Single-cell functional screening platform for antibody and drug discovery teams in biotech and pharma research
Highlights
- New on EvolcAdded 2026-10-28
About Lightcast Discovery
Lightcast develops Envisia, a platform for function-focused single-cell analysis. It combines instrumentation, a cartridge system based on oEWOD droplet processing, and software for designing, running and analysing experiments. The platform captures functional outputs such as biomolecule secretion, cell-cell interactions, cell killing and antibody blocking, and supports multi-step sequential assays with real-time export of live cells.
The platform is aimed at researchers working from basic and translational research through to drug discovery, including the discovery of antibodies and cellular therapies. Use cases include identifying optimal secretor cells and studying cell-cell communication and targeted cell killing. The company has opened sign-ups for early access to Envisia.
Lightcast is headquartered in Cambridge, United Kingdom, and was founded in 2019. Its leadership team includes a CEO, COO, CCO and several vice presidents and directors covering product, finance, science, IP and microfluidic products. The company lists open positions on its website.
Product: Envisia, an integrated single-cell functional analysis system with instrument, cartridge and control software.
Jobs at Lightcast Discovery
Leadership
- Paul Loeffen · CEOSource: company website
- Craig Tombling · COOSource: company website
- Paul Steinberg · CCOSource: company website
- Paul Wylie · VP of Product ManagementSource: company website
- Scott Brouilette · Director of MarketingSource: company website
More biotech & pharma companies
Liminal Biosciences
Develops small-molecule therapeutics for metabolic, inflammatory and fibrotic diseases through GPCR pathwaysNew on EvolcLindus Health
Clinical development of in-licensed drug assets for biotech and pharma partners, run on an AI clinical trial platformNew on EvolcRemote-friendlyMacomics
Macrophage-directed drugs that clear large disease protein complexes, first targeting IgA nephropathy patientsNew on EvolcMaxion Therapeutics
Engineered protein therapeutics for ion channel- and GPCR-driven diseasesNew on EvolcMC2 Therapeutics
Topical dermatology products, prescription and DermoCosmetic, for psoriasis and itchy, dry or sensitive skinNew on EvolcMdbiologics
UK healthcare company with separate websites for healthcare professionals and members of the publicYoung companyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- AWS
- Cloudflare
- Google Analytics 4
- Greenhouse
- Termly
- Webflow
- jQuery